Podcast appearances and mentions of donald kohn

Host: Matt Birnholz, MD Guest: Donald Kohn, MD Third-generation lentiviral vectors were developed to improve upon safety measures and mitigate the risks of toxicity and replication that are typically associated with first- and second-generation therapies. These advancements may help enhance the functionality and utility of third-generation lentiviral vectors in various gene therapy applications. Learn more about the development, efficacy, and safety of third-generation lentiviral vectors with Dr. Matt Birnholz and Dr. Donald Kohn, Distinguished Professor at the University of California, Los Angeles. This non-certified educational series is produced and controlled by ReachMD, and is intended for healthcare professionals only.

Donald Kohn, senior fellow in Economic Studies at Brookings and a former Federal Reserve vice chair, discusses why Silicon Valley Bank failed, what regulators did before and after the bank's collapse, and whether or not this event could signal additional global financial problems in the future. Show notes and transcript: https://bit.ly/3nK60Bo Dollar & Sense is part of the Brookings Podcast Network. Learn more at brookings.edu/podcasts, and send feedback to podcasts@brookings.edu.

Andrew Levin is a professor of economics at Dartmouth College and a former long-time Fed official. Andy is also a previous guest of Macro Musings and rejoins the podcast to talk about the costs and benefits of the Fed's QE4 program. David and Andy also discuss the Fed's recent record on inflation, QE4's impact on market functioning, the present and future of the Fed's balance sheet, and more.   Transcript for the episode can be found here.   Andrew's Dartmouth profile Andrew's NBER archive   David's Twitter: @DavidBeckworth Follow us on Twitter: @Macro_Musings Click here for the latest Macro Musings episodes sent straight to your inbox!   Related Links: *Quantifying the Costs and Benefits of Quantitative Easing* by Andrew Levin, Brian Lu, and William Nelson   *Incorporating Scenario Analysis into the Federal Reserve's Policy Strategy and Communications* by Michael Bordo, Andrew Levin, and Mickey Levy   *What if the Federal Reserve Books Losses Because of its Quantitative Easing?* by William English and Donald Kohn

George Selgin is a senior fellow and director emeritus of the Center for Monetary and Financial Alternatives at the Cato Institute. He is also the most frequent guest on Macro Musings, now appearing for his 12th time. In this episode, George and David identify and discuss their top three articles from the past few weeks related to macroeconomics and monetary policy. Specifically, George and Selgin discuss Lael Brainard's recent speech defending the Fed's prospects of issuing central bank digital currency, Janet Yellen's concession about the path that inflation has taken, the governmental accounting of Federal Reserve losses and whether they amount to a net taxpayer burden, why the Dollar remains firm as the dominant currency in global markets, how an orthodox corridor system defaults into a floor system during times of crisis, and much more.   Transcript for the episode can be found here.   George's Twitter: @GeorgeSelgin George's Cato profile   David's Twitter: @DavidBeckworth Follow us on Twitter: @Macro_Musings Click here for the latest Macro Musings episodes sent straight to your inbox!   Related Links:   *No, Fed, Unrealized Losses are Real Losses for Taxpayers* by Bill Nelson   *Preparing for the Financial System of the Future* speech by Lael Brainard at the 2022 U.S. Monetary Policy Forum   *What if the Federal Reserve Books Losses Because of its Quantitative Easing?* by Willam B. English and Donald Kohn    *From Burns to Powell*, a Macro Musings podcast episode with Guest Donald Kohn and host David Beckworth   *Treasury Secretary Concedes She Was Wrong on 'Path That Inflation Would Take'* By Kevin Liptak and Paul LeBlanc   *How Monetary Policy Got Behind The Curve And How To Get Back: A Policy Conference* Hoover Institution, Stanford University   *Jack Dorsey is Wrong. The Dollar is Still a Global Reserve Currency* by Mark Copelovitch   *A Model of Credit, Money, Interest, and Prices* by Saki Bigio and Yuliy Sannikov

Donald Kohn, senior fellow in Economic Studies at Brookings and a former vice chair of the Federal Reserve Board, joins David Dollar to explore a range of issues on inflation in the U.S., including how the COVID-19 pandemic and the macro response to it have contributed to inflation, the role of monetary and fiscal policy in addressing it, and how inflation affects trade and exchange rates. They end with some policy ideas for the Biden administration. Show notes and transcript: https://brook.gs/3sdtKg5  Dollar & Sense is part of the Brookings Podcast Network. Send feedback to podcasts@brookings.edu, and follow us on Twitter at @policypodcasts.

Show from 12/17/21Wharton Finance Professor Jeremy Siegel and Host Jeremy Schwartz talk to Former Vice Chair of the Federal Reserve Donald Kohn about inflation, the COVID-19 omicron variant, M2, inversion of the yield curve, and more. Professor Siegel notes the lagging labor force participation and its influence on inflation. Plus Donald gives his take on markets and recent fed decisions.Guest:Donald Kohn - Former Vice Chair of the Federal ReserveFor more information on Donald visit the Brookings Institution website: https://www.brookings.edu/experts/donald-kohn/ Follow WisdomTree on Twitter: @WisdomTreeETFsFollow Jeremy Schwartz on Twitter: @JeremyDSchwartz See acast.com/privacy for privacy and opt-out information.

Katherine High and Donald Kohn speak with senior editor Markus Elsner about the latest developments in gene therapy See acast.com/privacy for privacy and opt-out information.

Show from 5/14/21 Hosts Jeremy Schwartz and Wharton Finance Professor Jeremy Siegel talk Fed news and inflation with the former federal reserve vice chairman and an expert on equity strategy. Siegel says the inflation forecast is way above expectations and the fed needs to reevaluate the way they measure it. Guests:Donald Kohn - Former Federal Reserve Vice Chairman, Senior Fellow at the Brookings InstituteFor more on the Brookings Institute visit their website: https://www.brookings.edu/Follow Brookings Institute on Twitter: @BrookingsInstJames Lebenthal - Equity Strategist at Cerity PartnersFor more on Cerity Partners visit their website: https://ceritypartners.com/Follow James on Twitter: @jlebenthalFollow WisdomTree on Twitter: @WisdomTreeETFsFollow Jeremy Schwartz on Twitter: @JeremyDSchwartz See acast.com/privacy for privacy and opt-out information.

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

What impacts has stem cell research made for blood and immune system disorders? Hear the latest from experts in the field. Moderated by Crystal Mackall, MD, Stanford University Alysia Vaccaro: Patient Perspective Jennifer M Puck, MD, UC San Francisco: Gene Therapy for Artemis Severe Combined Immunodeficiency (ART-SCID) Donald B. Kohn, MD, UCLA: Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies Mark C. Walters, MD, UCSF Benioff Children's Hospital Oakland: Gene correction in Sickle Cell Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36332]

Donald Kohn joins Erik Torenberg (@eriktorenberg) to discuss the history of the Fed.

Title: Macro Musings Producers’ Special – A Recap of 2019 and a Glimpse into the Future   Description:   To accompany the new year, David Beckworth is joined by the producers of Macro Musings, Marc and Carter, to talk about the highlights of the podcast throughout 2019, including their personal favorite episodes and the top episodes according to listener statistics. They also discuss some of the most important macroeconomic issues and events of the past year, including the yield curve inversion and ensuing recession speculation, the secular decline of interest rates, the Fed’s big 2019 review, and more.   A massive thank you to all of our listeners who have tuned in over the past few years, and we hope you continue to tune in for more exciting content as we navigate through 2020.   David’s blog: macromarketmusings.blogspot.com David’s Twitter: @DavidBeckworth   Related Links:   Producers’ Top 3 Episodes:   Robert Graboyes: https://www.mercatus.org/bridge/podcasts/05132019/robert-graboyes-monetary-history-small-coins Bryan Cutsinger: https://www.mercatus.org/bridge/podcasts/03292019/civil-war-and-economics-seigniorage Salim Furth: https://www.mercatus.org/bridge/podcasts/06242019/land-use-regulations-rise-nimbyism-and-options-reform   Listeners’ Top 3 Episode:   Peter Stella: https://www.mercatus.org/bridge/podcasts/02182019/peter-stella-debt-safe-assets-and-central-bank-operations Tyler Cowen: https://www.mercatus.org/bridge/podcasts/07222019/tyler-cowen-culture-big-business-united-states Michael Strain: https://www.mercatus.org/bridge/podcasts/03042019/populism-mmt-and-billionaires   David’s Top 3 Episodes:   Donald Kohn: https://www.mercatus.org/bridge/podcasts/02012019/burns-powell Paul Tucker: https://www.mercatus.org/bridge/podcasts/03252019/paul-tucker-central-bank-independence-and-unelected-power Alex Tabarrok: https://www.mercatus.org/bridge/podcasts/09092019/alex-tabarrok-elements-economic-growth-and-decline-dynamism

The US Federal Reserve’s sharp pivot toward easing amid substantial White House pressure has raised concerns about central bank independence, as have developments in other advanced and emerging market economies alike. How worried we should be about this threat—and its implications for policy, the economy, and markets—is Top of Mind. In this episode, Goldman Sachs Research’s Allison Nathan interviews former central bankers Donald Kohn and Sir Paul Tucker who explain why central bank independence is critical to maintaining price and financial stability—even today when too little, rather than too much, inflation is the main problem. But while Kohn is concerned that Trump’s overt pressure could undermine Fed credibility, Tucker worries more that over-reliance on central banks since the GFC has left them vulnerable to politicization. Nathan also speaks with the firm’s chief economist Jan Hatzius who does not believe the Fed has responded directly to pressure from the White House, but does think that political pressure could already be influencing Fed policy through indirect channels such as bond market pricing. That said, Hatzius argues this in itself shouldn’t inflict too much harm on the economy unless inflationary pressures rise materially.

Donald Kohn is a senior fellow at the Brookings Institution and currently serves as an external member of the Financial Policy Committee at the Bank of England. Donald is also a 40-year veteran of the Federal Reserve System, serving previously as a governor and then as vice-chair of the Board of Governors from 2002 to 2010. He joins the show today to talk about his journey through the Federal Reserve System in addition to some of his recent work. David and Donald also discuss Fed policy during the ‘80s, expanding the types of assets the Fed could purchase, and the challenges it faces today.   Transcript for the episode: https://www.mercatus.org/bridge/podcasts/02012019/burns-powell   Donald’s Brookings profile: https://www.brookings.edu/experts/donald-kohn/ Donald’s Federal Reserve History biography: https://www.federalreservehistory.org/people/donald_l_kohn   Related Links:   *The Anguish of Central Banking* by Arthur Burns http://www.perjacobsson.org/lectures/1979.pdf   *Secrets of the Temple: How the Federal Reserve Runs the Country* by William Greider https://www.simonandschuster.com/books/Secrets-of-the-Temple/William-Greider/9780671675561   *Keeping At It: The Quest for Sound Money and Good Government* by Paul Volcker https://www.publicaffairsbooks.com/titles/paul-volcker/keeping-at-it/9781541788299/   David’s blog: macromarketmusings.blogspot.com David’s Twitter: @DavidBeckworth

Researchers at UCLA have developed a stem cell gene therapy treatment for children born with the rare, life-threatening condition ADA-deficient SCID, often referred to as Bubble Baby disease. Children born with this condition are without a functioning immune system and are kept in controlled and isolated environments because exposure to common illnesses or infections can be lethal. We spoke to the treatment’s developer Donald Kohn of the UCLA Eli and Edythe Broad Center of Regenerative Medicine about the stem cell gene therapy, the promising results he’s had restoring normal immune function in clinical trial patients, and why this approach holds promise in other rare conditions.

This seminar was given by Donald Kohn, former Vice Chairman of the Board of Governors of the Federal Reserve. He was introduced by Lucas Papademos, former Prime Minister of Greece. It was held on April 17, 2014 as part of M-RCBG’s business and government seminar series.

MONDAY, July 23, 2012 - 3:30 pm PST/6:30 pm EST BACK BY POPULAR DEMAND - Our incredible special guest is Jan A. Nolta, Ph.D., the Director of the Stem Cell Program at UC Davis School of Medicine, and directs the new Institute for Regenerative Cures. The UC Davis stem cell program has over 150 faculty members collaborating to work toward stem cell-related cures for a spectrum of diseases and injuries.   Dr. Nolta's laboratory focuses on “bench to the bedside” research, and she has been involved in numerous clinical trials of cell therapy. In 1994 she developed her passion for cellular therapy by assisting with the first umbilical cord blood stem cell gene therapy trials for newborns with “bubble baby disease”, with her mentor Donald Kohn at Children's Hospital of Los Angeles.   A scientist with more than 20 years' experience with human stem cells, Dr. Nolta has published over 100 manuscripts in the stem cell field and has authored 25 book chapters. She has served on over 200 grant review panels for the National Institutes of Health and other agencies, is Editor for the Journal “Stem Cells” and was editor of the Book "Genetic Engineering of Mesenchymal Stem Cells".   Dr. Nolta is a native of northern California and is extremely happy to be back in the area, since being recruited back to UC Davis from Washington University in 2007. The opportunity to help enhance stem cell research and development of therapies in her native Northern California was one of the leading draws to bring her back to the state.  www.jannolta.comwww.EndHD.org  

Monday, March 12, 2012 Our incredible special guest is Jan A. Nolta, Ph.D., the Director of the Stem Cell Program at UC Davis School of Medicine, and directs the new Institute for Regenerative Cures. The UC Davis stem cell program has over 150 faculty members collaborating to work toward stem cell-related cures for a spectrum of diseases and injuries. Dr. Nolta's laboratory focuses on “bench to the bedside” research, and she has been involved in numerous clinical trials of cell therapy. In 1994 she developed her passion for cellular therapy by assisting with the first umbilical cord blood stem cell gene therapy trials for newborns with “bubble baby disease”, with her mentor Donald Kohn at Children's Hospital of Los Angeles. A scientist with more than 20 years' experience with human stem cells, Dr. Nolta has published over 100 manuscripts in the stem cell field and has authored 25 book chapters. She has served on over 200 grant review panels for the National Institutes of Health and other agencies, is Editor for the Journal “Stem Cells” and was editor of the Book "Genetic Engineering of Mesenchymal Stem Cells". Dr. Nolta is a native of northern California and is extremely happy to be back in the area, since being recruited back to UC Davis from Washington University in 2007. The opportunity to help enhance stem cell research and development of therapies in her native Northern California was one of the leading draws to bring her back to the state.